Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.100K / 83.316K |
Day Range | - - - |
52 Wk Range | 0.850 - 6.000 |
Market Cap | $19.669M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 1.67% |
Days to Cover | 7.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mainz Biomed (NASDAQ: MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Vaxxinity (NASDAQ:VAXX) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Mainz Biomed (NASDAQ: MYNZ) was reported by Cantor Fitzgerald on Friday, April 12, 2024. The analyst firm set a price target for 0.00 expecting MYNZ to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $0.8987 last updated Today at April 25, 2024 at 7:42 AM EDT.
There are no upcoming dividends for Mainz Biomed.
Mainz Biomed’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.